Differences

This shows you the differences between two versions of the page.

--- publications [2026/04/01 09:20]
ramirez [2026]
+++ publications [2026/05/25 16:51] (current)
ramirez [2025]
@@ Line 2: / Line 2: @@
 ===== 2026  =====
-Mamede R, Vila-Cerqueira P, Carriço JA, [[people:ramirez|Ramirez M]]. 2026. <fc #0000FF>chewBBACA 3: lowering the barrier for scalable and detailed whole- and core-genome multilocus sequence typing</fc>. Genome Med //In press// [[https://doi.org/10.1186/s13073-026-01625-x| (doi:10.1186/s13073-026-01625-x).]]
+van Os J, de Jong HK, Pellejero-Sagastizabal G, Paño-Pardo JR, Lescure F-X, Hanscheid T, Grobusch MP, Goorhuis A. 2026. <fc #0000FF>Analysing outbreak signals, 2013-2024: the Amsterdam UMC centre for tropical medicine and travel medicine epi alert programme - an observational study</fc>. New Microbes New Infect 71:101756. [[https://www.ncbi.nlm.nih.gov/pubmed/42125210/|(PMID: 42125210)]].
+Grobusch MP, Adegbite BR, Hanscheid T, Gupta N. 2026. <fc #0000FF>The impact of state-of-the-art pharmacotherapy for malaria in infants: a breakthrough?</fc> Expert Opin Pharmacother 1–3 [[https://www.ncbi.nlm.nih.gov/pubmed/42059410/|(PMID: 42059410)]].
+Grobusch MP, Schnyder JL, Schlagenhauf P, de Jong HK, Hanscheid T. 2026. <fc #0000FF>Malaria prevention: progress to date</fc>. Drugs //In press// [[https://www.ncbi.nlm.nih.gov/pubmed/42045630/|(PMID: 42045630)]].
+Mamede R, Vila-Cerqueira P, Carriço JA, [[people:ramirez|Ramirez M]]. 2026. <fc #0000FF>chewBBACA 3: lowering the barrier for scalable and detailed whole- and core-genome multilocus sequence typing</fc>. Genome Med 18:51. [[https://www.ncbi.nlm.nih.gov/pubmed/41877275/|(PMID: 41877275)]].
+de Oliveira LOV, Ferreira LMSR, de Pereira DSCA, Firmino FT, Candal MS, Pereira HS, de Carli Farias da Silva G, Morellato SA, Geiger SM, Negrão-Corrêa D, Dollabella S, Fujiwara RT, Hanscheid T, Graeff-Teixeira C. 2026. <fc #0000FF>Modifications of the helmintex method: integration of treatments with tween 20, cellulase, percoll and auramine-O staining for detection of //Schistosoma mansoni// eggs</fc>. Trop med int health //In press// [[https://www.ncbi.nlm.nih.gov/pubmed/41830103/|(PMID: 41830103)]].
+Pereira DSC de A, Oliveira LOVO, Firmino FT, Hanscheid T, Pulak R, Jones M, Dolabella S, Negrão-Corrêa D, Graeff-Teixeira C. 2026. <fc #0000FF>Miracidia as main source for autofluorescence of //Schistosoma mansoni// eggs</fc>. Mem Inst Oswaldo Cruz 121:e250215. [[https://www.ncbi.nlm.nih.gov/pubmed/41810683/|(PMID: 41810683)]].
+van der Ende J, Davila MV, Coloma J, Schallig H, Hanscheid T, Grobusch MP. 2026. <fc #0000FF>Presence of dengue virus NS1 antigen and IgM and IgG antibodies in asymptomatic individuals in ecuadorian amazonia - a descriptive repeated cross-sectional community-based survey</fc>. New Microbes New Infect 70:101728. [[https://www.ncbi.nlm.nih.gov/pubmed/41783243/|(PMID: 41783243)]].
 Tsiodras S, Gupta N, Hanscheid T, Jokelainen P, Drexler JF, Barac A, Gkrania-Klotsas E, Mora-Rillo M, Bulescu C, Paño-Pardo JR, Lescure FX, Grobusch MP. 2026. <fc #0000FF>Language, trust, and the polio endgame: words matter in vaccine communication</fc>. Clin Microbiol Infect S1198-743X(26)00081–9. [[https://www.ncbi.nlm.nih.gov/pubmed/41765092/|(PMID: 41765092)]].
@@ Line 15: / Line 27: @@
 Mahomed SM, Hanscheid T, Almeida Y, Grobusch MP, Rebelo M. 2025. <fc #0000FF>Improving reproducibility of //Plasmodium falciparum// culture: a large-language-model-driven literature review and a parasite growth variability assessment of donor red blood cells</fc>. Malar J 25:46 [[https://www.ncbi.nlm.nih.gov/pubmed/41398683/|(PMID: 41398683)]].
-van der Ende J, Bezemer JM, Hanscheid T, Grobusch MP, Trueba G. 2025. Amazon environment sharing featuring humans - dogs - capybaras and more. Adapting a one-health approach to leptospirosis prevention in indigenous riverine communities in Ecuador and beyond. New Microbes New Infect 68:101658 [[https://www.ncbi.nlm.nih.gov/pubmed/41278579/|(PMID: 41278579)]].
+van der Ende J, Bezemer JM, Hanscheid T, Grobusch MP, Trueba G. 2025. <fc #0000FF>Amazon environment sharing featuring humans - dogs - capybaras and more. Adapting a one-health approach to leptospirosis prevention in indigenous riverine communities in Ecuador and beyond</fc>. New Microbes New Infect 68:101658 [[https://www.ncbi.nlm.nih.gov/pubmed/41278579/|(PMID: 41278579)]].
 Guerreiro-Nunes A, [[people:anacosta|Silva-Costa C]], [[people:jfsilva|Gomes-Silva J]], [[people:ramirez|Ramirez M]], [[people:jmelocristino|Melo-Cristino J]], Portuguese Group for the Study of Streptococcal Infections. 2025. <fc #0000FF>The resilience of vaccine serotypes in adult invasive pneumococcal disease in Portugal, 2018-2023</fc>. Sci Rep 15:40146. [[https://www.ncbi.nlm.nih.gov/pubmed/41249230/|(PMID: 41249230)]].
@@ Line 39: / Line 51: @@
 Stanley S, [[people:anacosta|Silva-Costa C]], [[people:jfsilva|Gomes-Silva J]], [[people:jmelocristino|Melo-Cristino J]], Malley R, [[people:ramirez|Ramirez M]]. 2025. <fc #0000FF>CC180 clade dynamics do not universally explain //Streptococcus pneumoniae// serotype 3 persistence post-vaccine: a global comparative population genomics study</fc>. Ebiomedicine 117:105781. [[https://www.ncbi.nlm.nih.gov/pubmed/40472804/|(PMID: 40472804)]]
-Carvalho BT, Meirinhos SV, Domingos GJ, Peixoto S, [[people:jmelocristino|Melo-Cristino J]]. 2025. <fc #0000FF>Unseen but unforgettable - refractive bacilli in the Gram stain of a muscular abscess</fc>. Eur J Clin Microbiol Infect Dis //In press// [[https://www.ncbi.nlm.nih.gov/pubmed/40307630/|(PMID: 40307630)]]
+Carvalho BT, Meirinhos SV, Domingos GJ, Peixoto S, [[people:jmelocristino|Melo-Cristino J]]. 2025. <fc #0000FF>Unseen but unforgettable - refractive bacilli in the Gram stain of a muscular abscess</fc>. Eur J Clin Microbiol Infect Dis 44:1749-1752 [[https://www.ncbi.nlm.nih.gov/pubmed/40307630/|(PMID: 40307630)]]
 Schnyder JL, de Jong HK, Bache EB, van Hest RM, Bélard S, Hanscheid T, Kremsner PG, Grobusch MP. 2025. <fc #0000FF>Which trial do we need? A randomised controlled study to compare the protective efficacy of early post-exposure discontinuation versus standard atovaquone-proguanil malaria prophylaxis in a human //Plasmodium falciparum// challenge model</fc>. Clin Microbiol Infect 31:1618–1622. [[https://www.ncbi.nlm.nih.gov/pubmed/40294866/|(PMID: 40294866)]]